elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35050195-D5033EEF-1348-4AA1-A591-4D355C990890
Q35050195-D5033EEF-1348-4AA1-A591-4D355C990890
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050195-D5033EEF-1348-4AA1-A591-4D355C990890
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.
P2093
Q35050195-D5033EEF-1348-4AA1-A591-4D355C990890
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050195-D5033EEF-1348-4AA1-A591-4D355C990890
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
baa26220c56b381126130f6ee4f22153d9b0fd2b
P1545
8
http://www.w3.org/2001/XMLSchema#string
P2093
Cheng-Pang Hsu
http://www.w3.org/2001/XMLSchema#string